TORONTO, ON--(Marketwired - Nov 11, 2013) - Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, is pleased to announce it has signed an agreement with Vortex Traffic to initiate and grow its online sales beginning with its TapouT brand of products. Since 2007 Vortex has produced over $140 million in global sales for its clients, primarily in the health and beauty industry.
Dr. Bagi, President of Axxess Pharma, stated, "We are thrilled to have signed a partnership with Vortex Traffic, where we expect to attain an online multi-country sales rate of up to 1,000 sales/day within the first six months of launch with our TapouT-branded products. The power of the TapouT brand continues to grow every month, as it evolves into an elite lifestyle brand gaining followers across a diverse spectrum." Dr. Bagi further stated, "Through this partnership with Vortex Traffic, we anticipate selling our TapouT-branded products to customers across North America and eventually around the world. Consumer demand for TapouT products in general is at an all-time high, and together with Vortex Traffic, we believe we can generate fast and sustainable revenue. Mr. Blazick (CEO of Vortex) is one of the most sought after online marketing experts in the world, with nearly 10 years of proven success."
Mr. Stephen Blazick, CEO of Vortex Traffic, stated, "We have already been successful with non branded products where marketing efforts on our part are substantially greater, and have been able to generate thousands of sales/day for our clients. We believe with the power of the TapouT brand that the speed at which we can reach that level will be much quicker and much more cost effective. We are absolutely thrilled to be promoting the TapouT brand with a partner such as AXXESS, who shares our long-term vision for achieving tremendous success through continual optimization and intelligent targeting."
About Vortex Traffic:
Vortex Traffic is a leading digital marketing firm based in Las Vegas, Nevada. Vortex specializes in complete campaign management and acquisitions of high performing media.
About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain, to optimal health management through improved nutritional supplements.
For more information, please visit www.axxesspharmainc.com, or contact Investor Relations at (973) 351-3868.
Safe Harbor Statement
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.
The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.